Nav: Home

HIPPO's molecular balancing act helps nerves not short circuit

April 26, 2017

CINCINNATI - Scientists write in Nature Communications it may be possible to therapeutically fine tune a constantly shifting balance of molecular signals to ensure the body's peripheral nerves are properly insulated and functioning normally. In a study published April 26, they suggest this may be a way to treat neuropathies or prevent the development of peripheral nerve sheath tumors.

The study was led by researchers at Cincinnati Children's Hospital Medical Center. It sought to identify the genetic and molecular networks that control the balanced proliferation and differentiation of Schwann cells in peripheral nerves -- a question that so far has remained unanswered. Schwann cells form a protective myelin sheath around nerves, which acts as insulation to ensure rapid transmission of neural signals to limbs and other parts of the body.

The researchers discovered that genetic dysfunction in what they call the HIPPO-TAZ/YAP and Gαs-protein feedback circuit disrupts the balanced production of Schwann cells.

If Schwann cell numbers are too sparse and widely-spaced, insufficient insulating myelin forms around nerves, leading to nerve insulation defects in the peripheral nerves of laboratory mice. An overabundance of Schwann cells in people with the genetic disorder neurofibromatosis 1 and 2 (who have mutations in the NF1 or NF2 tumor suppressor gene) has been linked to development of nerve sheath tumors.

"These findings will lead to future studies aimed at modulating or fine tuning the dynamic balance between YAP/TAZ and Gαs, and this may lead to new therapeutic strategies," said Q. Richard Lu, PhD, co-lead investigator and scientific director of the Brain Tumor Center at Cincinnati Children's. "These strategies would focus on promoting myelination in the peripheral nervous system for neuropathic disease or inhibiting Schwann cell over-proliferation that occurs during formation of peripheral nerve sheath tumors like neurofibromas."

Collaborating on the study was co-lead investigator Mei Xin, PhD, and co-first authors Yaqi Deng, PhD and Lai Man Natalie Wu, PhD (all in the Division of Experimental Biology and Cancer Biology at Cincinnati Children's).

The researchers stress that, because the study was conducted with mice, additional research is required before it can confirmed whether the data will apply directly to human health.

Affects 20 million people

An estimated 20 million people in the United States have some form of peripheral neuropathy, according to the National Institute of Neurological Disorders and Stroke.

The condition develops as a result of damage to the peripheral nervous system, a large network that transmits information between the central nervous system to other parts of the body. Symptoms can range from numbness, tingling, pricking sensations or muscle weakness. Some neuropathic conditions can become quite severe leading to paralysis.

HIPPO Pathway

The HIPPO molecular pathway works as a tumor suppressor that helps control organ development and size in most organisms, from fruit flies to humans. It exerts this control by regulating cell proliferation and transformation into specific organ cell types. When the pathway becomes dysregulated - as in during genetic mutation - it helps drive the development of tumors.

To understand how the HIPPO pathway controls Schwann cell proliferation and myelination, the researchers used genome-wide screens. This allowed them to identify specific genes that are turned on or off by co-regulators of gene function called TAZ and YAP in the nucleus of developing mouse Schwann cells. The molecules -- YAP (Yes-associated protein) and TAZ (PDZ-binding motif) -- are critical regulators of downstream genes and proteins that are important for the expansion and specification of myelin-forming Schwann cells.

The researchers also performed a transcriptome analysis comparing peripheral nerves with or without TAZ/YAP. This tells researchers which genes or signaling pathways are controlled by TAZ/YAP.

Gene occupancy and transcriptome tests revealed that, in immature Schwann cells, TAZ suppresses the expression of the gene that encodes the Gαs protein. When a Schwann cell is reaching maturity, the Gαs protein opposes the activities of TAZ and YAP. This decelerates cell expansion and allows the cells to develop and form myelin around peripheral nerves.

Combined, the molecular processes involving the HIPPO/TAZ/YAP and Gαs feedback circuit indicate it acts as a fulcrum that balances Schwann cell proliferation and differentiation in peripheral nerves, according to the authors. The finding also opens up new therapeutic avenues that can modulate and fine tune the processes to treat associated medical conditions.
Funding support for the research came in part from grants awarded by the National Institutes of Health (R01NS075243, R37NS096359), from the National Multiple Sclerosis Society (NMSS-4727) and from the National Natural Science Foundation of China.

Cincinnati Children's Hospital Medical Center

Related Tumor Suppressor Articles:

New results on the function of the tumor suppressor HERC protein
The RAF protein could be a therapeutical target to treat the tumor growth in regulated pathways by the p38 protein, according to a new study published in the journal Scientific Reports by a team of experts of the Faculty of Medicine and Health Sciences of the University of Barcelona and the Bellvitge Institute for Biomedical Research (IDIBELL).
New function for potential tumor suppressor in brain development
New research from the group of Simon Hippenmeyer, professor at the Institute of Science and Technology Austria (IST Austria), has now uncovered a novel, opposite role for Cdkn1c.
Researchers determine how a major tumor suppressor pathway becomes deactivated
The Hippo pathway is an important biological tumor suppressor program that controls cell growth and organ size in humans.
Nanoparticle therapeutic restores function of tumor suppressor in prostate cancer
Leveraging advances in mRNA and nanotechnology, investigators demonstrate that tumor suppressor PTEN can be restored in preclinical models of prostate cancer.
Discovery of a new tumor suppressor previously thought to be an oncogene
A gene that has for decades been considered a tumor promoter, the PLK1 gene, can also perform the exact opposite function: halting the development of cancer.
Unraveling role of tumor suppressor in gene expression & ovarian tumorigenesis
The tumor suppressor protein ARID1A controls global transcription in ovarian epithelial cells, according to new research conducted at The Wistar Institute, which provided mechanistic insight into tumorigenesis mediated by ARID1A loss in ovarian cancer.
Tumor suppressor protein plays key role in suppressing infections
Researchers have found that a previously uncharacterized tumor-suppressor protein plays an important role in the functioning of the immune system.
Tumor suppressor protein targets liver cancer
Salk Institute scientists, together with researchers from Switzerland's University of Basel and University Hospital Basel, discovered a protein called LHPP that acts as a molecular switch to turn off the uncontrolled growth of cells in liver cancer.
Stanford-led study uncovers mutation that supercharges tumor-suppressor
Stanford scientists have found an answer to one of cancer biology's toughest and most important questions: how does the body suppress tumors?
Injecting activator of a powerful tumor suppressor directly into the cancer increases tumor destruction, decreases toxicity
Directly injecting a tumor with an agent that activates a natural, powerful tumor suppressor enhances the drug's capacity to attack the tumor both locally and where it spreads, scientists report in the journal Cancer Research.
More Tumor Suppressor News and Tumor Suppressor Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at     You can read The Transition Integrity Project's report here.